HEADER TRANSCRIPTION 14-FEB-22 7TYP TITLE TEAD2 BOUND TO GNE-7883 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSCRIPTIONAL ENHANCER FACTOR TEF-4; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: TEA DOMAIN FAMILY MEMBER 2,TEAD-2; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TEAD2, TEF4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SMALL MOLECULE PPI INHIBITOR COMPLEX, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR C.L.NOLAND,R.FONG REVDAT 2 25-OCT-23 7TYP 1 REMARK REVDAT 1 03-MAY-23 7TYP 0 JRNL AUTH T.J.HAGENBEEK,J.R.ZBIEG,C.L.NOLAND,X.YAO,S.SCHMIDT, JRNL AUTH 2 S.CLAUSEN,M.STEFFEK,W.LEE,P.BEROZA,S.MARTIN,E.LIN,R.FONG, JRNL AUTH 3 P.DI LELLO,M.H.KUBALA,J.A.LACAP,M.N.Y.YANG,D.MADDALO, JRNL AUTH 4 J.T.LAU,L.AN,E.LEVY,M.N.LORENZO,H.J.LEE,T.H.PHAM,Z.MODRUSAN, JRNL AUTH 5 R.ZANG,Y.C.CHEN,J.LI,M.HAFNER,M.T.CHANG,J.J.CRAWFORD,A.DEY JRNL TITL NOVEL MECHANISM OF YAP-TEAD INHIBITION RESULTS IN TARGETED JRNL TITL 2 CHROMATIN REMODELING AND REVEALS AN EXPANDED HIPPO DEPENDENT JRNL TITL 3 LANDSCAPE IN CANCERS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.2_3874 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 71.21 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 60.7 REMARK 3 NUMBER OF REFLECTIONS : 42782 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.216 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.950 REMARK 3 FREE R VALUE TEST SET COUNT : 2117 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 71.2100 - 3.9400 0.99 4540 240 0.1583 0.1920 REMARK 3 2 3.9400 - 3.1300 0.92 4139 194 0.1568 0.1634 REMARK 3 3 3.1300 - 2.7300 0.98 4441 221 0.1945 0.2478 REMARK 3 4 2.7300 - 2.4800 0.95 4265 216 0.2063 0.2686 REMARK 3 5 2.4800 - 2.3000 0.99 4420 221 0.2043 0.2406 REMARK 3 6 2.3000 - 2.1700 0.88 3940 203 0.2068 0.2201 REMARK 3 7 2.1700 - 2.0600 0.77 3420 193 0.2105 0.2413 REMARK 3 8 2.0600 - 1.9700 0.75 3334 187 0.2144 0.2557 REMARK 3 9 1.9700 - 1.8900 0.44 1966 95 0.2222 0.2429 REMARK 3 10 1.8900 - 1.8300 0.51 2261 119 0.2484 0.2425 REMARK 3 11 1.8300 - 1.7700 0.38 1691 101 0.2664 0.2596 REMARK 3 12 1.7700 - 1.7200 0.27 1201 67 0.2778 0.3148 REMARK 3 13 1.7200 - 1.6700 0.15 677 37 0.2723 0.2405 REMARK 3 14 1.6700 - 1.6300 0.07 302 21 0.2958 0.3240 REMARK 3 15 1.6300 - 1.6000 0.01 68 2 0.3274 0.5030 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.173 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.060 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.63 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.52 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 3564 REMARK 3 ANGLE : 1.132 4876 REMARK 3 CHIRALITY : 0.070 534 REMARK 3 PLANARITY : 0.007 666 REMARK 3 DIHEDRAL : 21.512 1367 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7TYP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-FEB-22. REMARK 100 THE DEPOSITION ID IS D_1000263159. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-OCT-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42783 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.597 REMARK 200 RESOLUTION RANGE LOW (A) : 71.210 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 60.7 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5EMV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.56 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M NA/K TARTRATE, 0.1 M BIS TRIS PH REMARK 280 6.5, 35% PEG 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 61.48500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.71500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 61.48500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 30.71500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 260 REMARK 465 PRO A 261 REMARK 465 GLY A 262 REMARK 465 ALA A 263 REMARK 465 PRO A 264 REMARK 465 PRO A 310 REMARK 465 SER A 311 REMARK 465 GLY A 312 REMARK 465 GLU A 313 REMARK 465 GLU A 314 REMARK 465 ALA A 315 REMARK 465 GLY A 316 REMARK 465 ALA A 317 REMARK 465 GLY A 318 REMARK 465 GLY A 319 REMARK 465 SER A 320 REMARK 465 ILE A 321 REMARK 465 SER A 322 REMARK 465 SER A 323 REMARK 465 GLY A 324 REMARK 465 ASP A 447 REMARK 465 ALA B 217 REMARK 465 TRP B 218 REMARK 465 GLN B 219 REMARK 465 ALA B 220 REMARK 465 ARG B 221 REMARK 465 PRO B 240 REMARK 465 ASP B 241 REMARK 465 ALA B 242 REMARK 465 VAL B 243 REMARK 465 ASP B 244 REMARK 465 SER B 245 REMARK 465 TYR B 246 REMARK 465 GLN B 247 REMARK 465 HIS B 257 REMARK 465 CYS B 258 REMARK 465 PRO B 259 REMARK 465 SER B 260 REMARK 465 PRO B 261 REMARK 465 GLY B 262 REMARK 465 ALA B 263 REMARK 465 GLY B 309 REMARK 465 PRO B 310 REMARK 465 SER B 311 REMARK 465 GLY B 312 REMARK 465 GLU B 313 REMARK 465 GLU B 314 REMARK 465 ALA B 315 REMARK 465 GLY B 316 REMARK 465 ALA B 317 REMARK 465 GLY B 318 REMARK 465 GLY B 319 REMARK 465 SER B 320 REMARK 465 ILE B 321 REMARK 465 SER B 322 REMARK 465 SER B 323 REMARK 465 GLY B 324 REMARK 465 ASP B 447 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 CYS A 258 SG REMARK 470 GLU A 267 CG CD OE1 OE2 REMARK 470 ARG A 272 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 280 CG CD OE1 OE2 REMARK 470 LYS A 281 CG CD CE NZ REMARK 470 LYS A 282 CG CD CE NZ REMARK 470 ARG A 286 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 287 CG CD OE1 OE2 REMARK 470 ARG A 291 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 419 CG CD OE1 OE2 REMARK 470 GLN B 256 CG CD OE1 NE2 REMARK 470 ARG B 272 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 273 CG CD OE1 NE2 REMARK 470 ASP B 276 CG OD1 OD2 REMARK 470 LYS B 281 CG CD CE NZ REMARK 470 LYS B 282 CG CD CE NZ REMARK 470 ARG B 286 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 291 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 367 CG OD1 OD2 REMARK 470 GLU B 381 CG CD OE1 OE2 REMARK 470 SER B 433 OG REMARK 470 GLU B 434 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 345 OE1 GLN A 410 2.04 REMARK 500 OG SER B 345 OE1 GLN B 410 2.07 REMARK 500 O TYR B 275 NZ LYS B 277 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 780 O HOH A 780 2556 1.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 390 CA - CB - CG ANGL. DEV. = 14.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 282 73.20 56.37 REMARK 500 LYS B 281 -128.32 49.25 REMARK 500 REMARK 500 REMARK: NULL DBREF 7TYP A 217 447 UNP Q15562 TEAD2_HUMAN 217 447 DBREF 7TYP B 217 447 UNP Q15562 TEAD2_HUMAN 217 447 SEQRES 1 A 231 ALA TRP GLN ALA ARG GLY LEU GLY THR ALA ARG LEU GLN SEQRES 2 A 231 LEU VAL GLU PHE SER ALA PHE VAL GLU PRO PRO ASP ALA SEQRES 3 A 231 VAL ASP SER TYR GLN ARG HIS LEU PHE VAL HIS ILE SER SEQRES 4 A 231 GLN HIS CYS PRO SER PRO GLY ALA PRO PRO LEU GLU SER SEQRES 5 A 231 VAL ASP VAL ARG GLN ILE TYR ASP LYS PHE PRO GLU LYS SEQRES 6 A 231 LYS GLY GLY LEU ARG GLU LEU TYR ASP ARG GLY PRO PRO SEQRES 7 A 231 HIS ALA PHE PHE LEU VAL LYS PHE TRP ALA ASP LEU ASN SEQRES 8 A 231 TRP GLY PRO SER GLY GLU GLU ALA GLY ALA GLY GLY SER SEQRES 9 A 231 ILE SER SER GLY GLY PHE TYR GLY VAL SER SER GLN TYR SEQRES 10 A 231 GLU SER LEU GLU HIS MET THR LEU THR CYS SER SER LYS SEQRES 11 A 231 VAL CYS SER PHE GLY LYS GLN VAL VAL GLU LYS VAL GLU SEQRES 12 A 231 THR GLU ARG ALA GLN LEU GLU ASP GLY ARG PHE VAL TYR SEQRES 13 A 231 ARG LEU LEU ARG SER PRO MET CYS GLU TYR LEU VAL ASN SEQRES 14 A 231 PHE LEU HIS LYS LEU ARG GLN LEU PRO GLU ARG TYR MET SEQRES 15 A 231 MET ASN SER VAL LEU GLU ASN PHE THR ILE LEU GLN VAL SEQRES 16 A 231 VAL THR ASN ARG ASP THR GLN GLU LEU LEU LEU CYS THR SEQRES 17 A 231 ALA TYR VAL PHE GLU VAL SER THR SER GLU ARG GLY ALA SEQRES 18 A 231 GLN HIS HIS ILE TYR ARG LEU VAL ARG ASP SEQRES 1 B 231 ALA TRP GLN ALA ARG GLY LEU GLY THR ALA ARG LEU GLN SEQRES 2 B 231 LEU VAL GLU PHE SER ALA PHE VAL GLU PRO PRO ASP ALA SEQRES 3 B 231 VAL ASP SER TYR GLN ARG HIS LEU PHE VAL HIS ILE SER SEQRES 4 B 231 GLN HIS CYS PRO SER PRO GLY ALA PRO PRO LEU GLU SER SEQRES 5 B 231 VAL ASP VAL ARG GLN ILE TYR ASP LYS PHE PRO GLU LYS SEQRES 6 B 231 LYS GLY GLY LEU ARG GLU LEU TYR ASP ARG GLY PRO PRO SEQRES 7 B 231 HIS ALA PHE PHE LEU VAL LYS PHE TRP ALA ASP LEU ASN SEQRES 8 B 231 TRP GLY PRO SER GLY GLU GLU ALA GLY ALA GLY GLY SER SEQRES 9 B 231 ILE SER SER GLY GLY PHE TYR GLY VAL SER SER GLN TYR SEQRES 10 B 231 GLU SER LEU GLU HIS MET THR LEU THR CYS SER SER LYS SEQRES 11 B 231 VAL CYS SER PHE GLY LYS GLN VAL VAL GLU LYS VAL GLU SEQRES 12 B 231 THR GLU ARG ALA GLN LEU GLU ASP GLY ARG PHE VAL TYR SEQRES 13 B 231 ARG LEU LEU ARG SER PRO MET CYS GLU TYR LEU VAL ASN SEQRES 14 B 231 PHE LEU HIS LYS LEU ARG GLN LEU PRO GLU ARG TYR MET SEQRES 15 B 231 MET ASN SER VAL LEU GLU ASN PHE THR ILE LEU GLN VAL SEQRES 16 B 231 VAL THR ASN ARG ASP THR GLN GLU LEU LEU LEU CYS THR SEQRES 17 B 231 ALA TYR VAL PHE GLU VAL SER THR SER GLU ARG GLY ALA SEQRES 18 B 231 GLN HIS HIS ILE TYR ARG LEU VAL ARG ASP HET TRS A 601 16 HET KUR A 602 66 HET KUR B 501 66 HETNAM TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL HETNAM KUR (8S)-5-(4-CYCLOHEXYLPHENYL)-3-[3-(FLUOROMETHYL) HETNAM 2 KUR AZETIDINE-1-CARBONYL]-2-(3-METHYLPYRAZIN-2-YL) HETNAM 3 KUR PYRAZOLO[1,5-A]PYRIMIDIN-7(4H)-ONE HETSYN TRS TRIS BUFFER FORMUL 3 TRS C4 H12 N O3 1+ FORMUL 4 KUR 2(C28 H29 F N6 O2) FORMUL 6 HOH *189(H2 O) HELIX 1 AA1 PRO A 239 ASP A 244 5 6 HELIX 2 AA2 ARG A 272 PHE A 278 5 7 HELIX 3 AA3 GLY A 284 GLY A 292 1 9 HELIX 4 AA4 PRO A 293 HIS A 295 5 3 HELIX 5 AA5 CYS A 380 GLN A 392 1 13 HELIX 6 AA6 GLU A 395 GLU A 404 1 10 HELIX 7 AA7 ARG B 272 TYR B 275 5 4 HELIX 8 AA8 GLY B 284 GLY B 292 1 9 HELIX 9 AA9 PRO B 293 HIS B 295 5 3 HELIX 10 AB1 CYS B 380 ARG B 391 1 12 HELIX 11 AB2 GLU B 395 GLU B 404 1 10 SHEET 1 AA1 5 HIS A 249 SER A 255 0 SHEET 2 AA1 5 GLN A 229 GLU A 238 -1 N PHE A 233 O ILE A 254 SHEET 3 AA1 5 PHE A 326 SER A 335 -1 O GLN A 332 N VAL A 231 SHEET 4 AA1 5 ARG A 369 PRO A 378 -1 O PHE A 370 N SER A 335 SHEET 5 AA1 5 GLN A 364 GLU A 366 -1 N GLU A 366 O ARG A 369 SHEET 1 AA214 SER A 268 ASP A 270 0 SHEET 2 AA214 GLN A 438 VAL A 445 1 O VAL A 445 N VAL A 269 SHEET 3 AA214 PHE A 297 ALA A 304 -1 N LEU A 299 O TYR A 442 SHEET 4 AA214 LEU A 420 VAL A 430 1 O GLU A 429 N ALA A 304 SHEET 5 AA214 PHE A 406 ASN A 414 -1 N ILE A 408 O TYR A 426 SHEET 6 AA214 THR A 340 SER A 349 -1 N CYS A 348 O THR A 407 SHEET 7 AA214 LYS A 352 ARG A 362 -1 O GLU A 359 N CYS A 343 SHEET 8 AA214 LYS B 352 ARG B 362 1 O VAL B 358 N VAL A 358 SHEET 9 AA214 THR B 340 SER B 349 -1 N VAL B 347 O VAL B 354 SHEET 10 AA214 PHE B 406 ASN B 414 -1 O THR B 407 N CYS B 348 SHEET 11 AA214 LEU B 420 VAL B 430 -1 O LEU B 421 N VAL B 412 SHEET 12 AA214 PHE B 297 ALA B 304 1 N ALA B 304 O GLU B 429 SHEET 13 AA214 GLN B 438 VAL B 445 -1 O GLN B 438 N TRP B 303 SHEET 14 AA214 GLU B 267 ASP B 270 1 N GLU B 267 O ARG B 443 SHEET 1 AA3 5 HIS B 249 ILE B 254 0 SHEET 2 AA3 5 GLN B 229 GLU B 238 -1 N PHE B 233 O ILE B 254 SHEET 3 AA3 5 PHE B 326 SER B 335 -1 O GLY B 328 N PHE B 236 SHEET 4 AA3 5 ARG B 369 PRO B 378 -1 O SER B 377 N VAL B 329 SHEET 5 AA3 5 GLN B 364 GLU B 366 -1 N GLU B 366 O ARG B 369 CISPEP 1 GLY A 292 PRO A 293 0 1.80 CISPEP 2 GLY B 292 PRO B 293 0 -3.33 CRYST1 122.970 61.430 80.052 90.00 117.18 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008132 0.000000 0.004175 0.00000 SCALE2 0.000000 0.016279 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014042 0.00000